Skip to main content
. 2020 Jun 25;3(6):e208958. doi: 10.1001/jamanetworkopen.2020.8958

Table 2. Description of 30-Day Postcolonoscopy Complications.

Characteristic No. (%) P valuea
Total (N = 38 069) CRC screening-eligible cohort (n = 30 443) Older cohort (n = 7626)
Admission or ED visit 1310 (3.4) 795 (2.6) 515 (6.8) <.001
Postcolonoscopy bleeding 141 (0.4) 76 (0.2) 65 (0.9) <.001
Bowel perforation 18 (0.05) 12 (0.04) 6 (0.08) .15
Cardiovascular-related admissions 274 (0.7) 138 (0.5) 136 (1.8) <.001
Nongastrointestinal malignancy 149 (0.4) 97 (0.3) 52 (0.7) <.001
Infection-related admissions 148 (0.4) 93 (0.3) 95 (1.2) <.001
Colorectal surgeryb 65 (0.2) 47 (0.2) 18 (0.2) .12
Nonsurgically treated CRC 20 (0.1) 13 (0.04) 7 (0.1) .09
Diverticular disease 27 (0.07) 21 (0.07) 6 (0.08) .78
Palliative care 27 (0.07) 19 (0.06) 8 (0.1) .21
Other 401 (1.1) 279 (0.9) 122 (1.6) <.001

Abbreviations: CRC, colorectal cancer; ED, emergency department.

a

Hypothesis testing was carried out with χ2 or Fisher exact test.

b

Unrelated to CRC.